Provided by Tiger Trade Technology Pte. Ltd.

PharmaCyte Biotech, Inc.

0.7178
-0.0694-8.82%
Post-market: 0.76680.0490+6.82%19:22 EDT
Volume:205.49K
Turnover:155.08K
Market Cap:7.71M
PE:-0.71
High:0.8007
Open:0.7800
Low:0.7178
Close:0.7872
52wk High:1.51
52wk Low:0.6300
Shares:10.74M
Float Shares:9.96M
Volume Ratio:1.42
T/O Rate:2.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0080
EPS(LYR):3.19
ROE:-8.24%
ROA:-6.75%
PB:0.20
PE(LYR):0.23

Loading ...

Apr 02, 2026

Major Issues Report

Form 8-K - Current report
Mar 17, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dec 18, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dec 05, 2025

Major Issues Report

Form 8-K - Current report
Nov 18, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Oct 31, 2025

Major Issues Report

Form 8-K - Current report
Sep 25, 2025

Correspondence

Form CORRESP - Correspondence
Sep 15, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 05, 2025

Major Issues Report

Form 8-K - Current report
Aug 18, 2025

Major Issues Report

Form 8-K - Current report
Aug 09, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 24, 2025

Major Issues Report

Form 8-K - Current report
Mar 17, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Dec 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dec 04, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 17, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
May 31, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership